Get the latest tech news
Lindus Health raises $55M to ‘fix the broken clinical trial industry’
Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry."
The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new medicines to market quicker. Moreover, Lindus plans to invest more resources in its commercial go-to-market team, expand into “more complex” clinical trial types, and bolster its integrations with third-party tooling such as electronic medical records. Prior to joining TechCrunch in June 2022, Paul had gained more than a decade’s experience covering consumer and enterprise technologies for The Next Web (now owned by the Financial Times) and VentureBeat.
Or read this on TechCrunch